GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » Net Investment Income

Progen Co (XKRX:296160) Net Investment Income


View and export this data going back to 2023. Start your Free Trial

What is Progen Co Net Investment Income?

Net Investment Income only applies to insurance companies.


Progen Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
172 Magokjungang-ro, 7th Floor, Bio Innovation Park, Gangseo-gu, Seoul, KOR
Progen Co Ltd is an R&D focused biopharmaceutical development venture. It is engaged in developing metabolic disease treatments, immune disease treatments, and immune anti cancer drugs using its immunology based drug development know how, and is focusing on developing inventive drugs through domestic and international open innovation.